DSS, INC. (DSS) - 10-Q Summary for Period Ended June 30, 2024
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. DSS, Inc. operates nine distinct business lines organized into five reporting segments: Product Packaging, Commercial Lending, Direct Marketing, Biotechnology, and Securities and Investment Management. The company is a non-accelerated filer and a smaller reporting company. A significant structural change occurred in the prior year with the deconsolidation of Sharing Services Global Corporation (SHRG) effective May 1, 2023, which drastically altered the revenue base for the Direct Marketing segment.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2024 | Six Months Ended June 30, 2023 |
|---|---|---|
| Total Revenue | $8,082,000 | $19,064,000 |
| Net Loss | $(10,063,000) | $(46,357,000) |
| Net Loss Attributable to Common Stockholders | $(8,754,000) | $(45,959,000) |
| Operating Loss | $(9,616,000) | $(12,125,000) |
| Cash and Cash Equivalents (Ending) | $10,719,000 | $10,033,000 |
| Net Cash Used in Operating Activities | $(5,574,000) | $(19,715,000) |
| Total Debt (Current + Long-Term) | $56,159,000 | $55,227,000 |
| Assets Held for Sale | $46,040,000 | $2,004,000 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 58% year-over-year. This is primarily driven by a 100% drop in Direct Marketing revenue due to the 2023 deconsolidation of SHRG. Rental income fell 74% due to tenant payment issues at AMRE LifeCare facilities. Printed products revenue declined 32% due to order timing shifts.
- Improved Net Loss: Net loss improved significantly (78% reduction) compared to the prior year. The 2023 period included a massive one-time loss of approximately $29.2 million related to the deconsolidation of SHRG, which is absent in the current period.
- Investment Losses: Loss on investments decreased from $30.8 million in 2023 to $0.6 million in 2024, largely due to the absence of the SHRG deconsolidation charge.
- Asset Restructuring: Assets held for sale increased to $46.0 million, primarily consisting of medical facilities (AMRE LifeCare and AMRE Winter Haven) and retail space, reflecting a strategic shift to liquidate non-core real estate.
- Loan Loss Provisions: Provision for loan losses dropped from $3.8 million in 2023 to $0.3 million in 2024, though significant specific reserves remain for related-party and commercial borrowers.
Outlook, Risks, and Management Commentary
- Liquidity and Going Concern: Management states that substantial doubt regarding the company's ability to continue as a going concern has been alleviated. This is based on $10.7 million in cash, the ability to sell $9.6 million in marketable securities, and the planned sale of $46.0 million in real estate assets held for sale.
- Debt Covenants and Defaults: Significant portions of long-term debt related to AMRE LifeCare and AMRE Winter Haven are in default, with demand for final payment made in late 2023. These amounts are classified as current liabilities.
- Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting that remained as of June 30, 2024. Management is implementing a remediation plan, but controls are currently deemed ineffective.
- Segment Performance: The Product Packaging segment remains the primary revenue generator but faces margin pressure. The Securities segment holds significant assets but incurred losses due to unrealized losses on marketable securities and high interest expenses on related-party loans.
Investor Verification Checklist
- Debt Default Status: Verify the current status of the defaulted AMRE LifeCare and Winter Haven loans and any potential foreclosure or restructuring agreements.
- Asset Sale Progress: Confirm the timeline and likelihood of selling the $46 million in assets held for sale, as this is critical to the company's liquidity plan.
- Related Party Loans: Review the collectability of notes receivable from related parties (e.g., Borrower 8, Borrower 10), many of which are fully or partially reserved.
- Internal Control Remediation: Assess the progress of the remediation plan for material weaknesses in internal controls to ensure future financial reporting reliability.
- Revenue Concentration: Note that one customer accounted for 24% of consolidated revenue and 39% of trade accounts receivable as of June 30, 2024.